Sponsor Check › Person
Related person on Form D filings · address states as listed: CA, CT · listed Oct 27, 2009 → Mar 20, 2024
Data last updated: Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:20 AM ET · SEC enforcement last checked: not yet
Privacy: business-related public information only. Residential addresses are never shown; only the state from the filing.
The five facts investors ask about first. Each section states what was searched and when. Items still in human review are not shown.
None found in sources searched.
Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts; live RECAP re-check pending. State courts: not yet searched. PACER: not searched. · Last checked Oct 24, 2026, 2:20 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — not yet searched; State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states: not yet searched.
Not yet searched.
No SEC search has run yet for this person.
None found in sources searched.
Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not yet searched. PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:20 AM ET.
State courts: not yet searched. No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.
Comparisons are made for sponsors and sponsor groups, not individual people.
2 of 32 offerings report sales commissions totalling $5,150,000; 0 report finder's fees; 4 report proceeds to related persons totalling $3,790,000. (includes amounts the issuer reported as estimates)
| Source | Offering (latest filing) | Sales commissions | Finder's fees | To insiders | Paid to sell it |
|---|---|---|---|---|---|
| EDGAR ↗ | Mar 20, 2024 D File 021-508154 | $3,500,000 | $0 | $0 | Leerink Partners LLC BrokerCheck CRD 39011 ↗ Piper Sandler & Co. BrokerCheck CRD 665 ↗ |
| EDGAR ↗ | Mar 13, 2023 D File 021-475696 | $1,650,000 | $0 | $0 | EF Hutton, division of Benchmark Investments LLC BrokerCheck CRD 103792 ↗ |
| EDGAR ↗ | Aug 5, 2022 D File 021-454973 | $0 | $0 | $10,000 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2022 D File 021-450069 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 23, 2022 D File 021-450070 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 2, 2022 D/A File 021-428646 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 4, 2020 D File 021-379636 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 4, 2020 D File 021-379637 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 4, 2020 D File 021-379638 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 3, 2020 D File 021-368252 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 16, 2019 D File 021-346819 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Mar 4, 2019 D File 021-334016 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 19, 2017 D File 021-288959 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Aug 31, 2016 D File 021-269835 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 4, 2016 D File 021-254412 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 21, 2015 D File 021-253551 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 10, 2015 D/A File 021-248799 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 12, 2015 D File 021-239651 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Feb 12, 2015 D File 021-233986 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 7, 2014 D File 021-220464 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jun 28, 2013 D File 021-198761 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 2, 2013 D File 021-195883 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 29, 2013 D File 021-190972 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Dec 27, 2012 D File 021-188988 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Nov 21, 2012 D File 021-187380 | $0 | $0 | $1,700,000 (est.) Proceeds are for general working capital, a portion of which will be used for management compensation. | None listed on this filing |
| EDGAR ↗ | May 7, 2012 D File 021-177735 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jan 5, 2012 D File 021-171188 | $0 | $0 | $800,000 (est.) Proceeds are for general working capital, a portion of which will be used for management compensation. | None listed on this filing |
| EDGAR ↗ | Dec 14, 2011 D/A File 021-162638 | $0 | $0 | $1,280,000 (est.) Proceeds are for general working capital, a portion of which will be used for management compensation. | None listed on this filing |
| EDGAR ↗ | Sep 20, 2011 D File 021-166106 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | May 20, 2011 D File 021-160139 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Jul 28, 2010 D File 021-145562 | $0 | $0 | $0 | None listed on this filing |
| EDGAR ↗ | Oct 27, 2009 D File 021-77060 | $0 | $0 | $0 | None listed on this filing |
As reported by the issuer on Form D (Items 12–15), latest filing per offering (one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.
Counted across every filing this person is listed on (latest filing per offering, per issuer).
| Source | Issuer | Role | Filed | Form | Offering | Sold | Investors | Min. investment |
|---|---|---|---|---|---|---|---|---|
| EDGAR ↗ | Unicycive Therapeutics, Inc. | Director | Mar 20, 2024 | D | $50,000,000 similar: $2,000,000–$19,999,994 | $50,000,000 | 25 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Unicycive Therapeutics, Inc. | Director | Mar 13, 2023 | D | $30,190,000 similar: $2,000,000–$19,999,994 | $30,190,000 | 20 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Karmanterra LLC | Director | Aug 5, 2022 | D | $220,000 similar: $1,100,015–$10,001,163 | $84,000 | 3 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Encina Private Credit Holdco, LLC group: Oaktree | Executive Officer, Director Board Director and President | Jun 23, 2022 | D | $1,666,666 similar: $2,144,500–$20,220,000 | $1,415,000 | 2 similar: 2–24 | No minimum reported similar: $10,000–$100,000 |
| EDGAR ↗ | Encina Private Credit Intermediate Holdco, LLC group: Oaktree | Executive Officer, Director Board Director and President | Jun 23, 2022 | D | Indefinite similar: $2,144,500–$20,220,000 | $200,000,100 | 2 similar: 2–24 | No minimum reported similar: $10,000–$100,000 |
| EDGAR ↗ | Artists for Artists Inc. | Executive Officer, Director | Feb 2, 2022 | D/A | $4,000,000 similar: $500,000–$5,000,000 | $2,795,000 | 16 similar: 2–15 | $1 similar: $6,225–$50,000 |
| EDGAR ↗ | Artists for Artists Inc. | Executive Officer, Director | Jan 10, 2022 | D | $10,000 similar: $500,000–$5,000,000 | $10,000 | 13 similar: 2–15 | $1 similar: $6,225–$50,000 |
| EDGAR ↗ | Encina Lender Finance, LLC group: Oaktree | Executive Officer, Director Board Director and Vice President | Nov 4, 2020 | D | $3,618,462 similar: $2,144,500–$20,220,000 | $3,618,462 | 5 similar: 2–24 | No minimum reported similar: $10,000–$100,000 |
| EDGAR ↗ | Encina Lender Finance Intermediate SPV, LLC group: Oaktree | Executive Officer, Director Board Director and Vice President | Nov 4, 2020 | D | Indefinite similar: $2,144,500–$20,220,000 | $100,000,100 | 2 similar: 2–24 | No minimum reported similar: $10,000–$100,000 |
| EDGAR ↗ | Encina Capital Group, LLC group: Oaktree | Director | Nov 4, 2020 | D | $3,800,000 similar: $2,144,500–$20,220,000 | $3,800,000 | 11 similar: 2–24 | No minimum reported similar: $10,000–$100,000 |
| EDGAR ↗ | Unicycive Therapeutics, Inc. | Director | Jun 3, 2020 | D | $604,140 similar: $2,000,000–$19,999,994 | $604,140 | 15 similar: 2–16 | No minimum reported similar: $10,000–$50,000 |
| EDGAR ↗ | Unicycive Therapeutics, Inc. | Director | Aug 16, 2019 | D | $526,950 similar: $2,000,000–$19,999,994 | $526,950 | 9 similar: 2–16 | $50,000 similar: $10,000–$50,000 |
| EDGAR ↗ | Unicycive Therapeutics, Inc. | Director | Mar 4, 2019 | D | $420,000 similar: $2,000,000–$19,999,994 | $420,000 | 8 similar: 2–16 | $50,000 similar: $10,000–$50,000 |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | Jun 19, 2017 | D | $28,871,388 similar: $829,831–$9,999,998 | $28,783,669 | 21 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Relievant MedSystems, Inc. | Director | Aug 31, 2016 | D | $52,214,701 similar: $500,000–$7,000,000 | $22,164,015 | 10 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Relievant MedSystems, Inc. | Director | Jan 4, 2016 | D | $49,203 similar: $500,000–$7,000,000 | $49,203 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Relievant MedSystems, Inc. | Director | Dec 21, 2015 | D | $3,000,000 similar: $500,000–$7,000,000 | $1,500,000 | 5 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | Globavir Biosciences Inc. | Director | Nov 10, 2015 | D/A | $10,010,000 similar: $2,000,000–$14,000,000 | $150,000 | 1 similar: 1–19 | $49,998 similar: $10,000–$50,000 |
| EDGAR ↗ | Globavir Biosciences Inc. | Director | Oct 6, 2015 | D | $10,000,000 similar: $2,000,000–$14,000,000 | $100,000 | 1 similar: 1–19 | $50,000 similar: $10,000–$50,000 |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | May 12, 2015 | D | $12,000,000 similar: $829,831–$9,999,998 | $5,971,186 | 21 similar: 2–15 | No minimum reported similar: $10,000–$54,310 |
| EDGAR ↗ | Relievant MedSystems, Inc. | Director | Feb 12, 2015 | D | $5,000,000 similar: $500,000–$7,000,000 | $3,000,000 | 6 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | VALERITAS INC | Director | Jul 7, 2014 | D | $45,000,000 similar: $1,100,015–$10,001,163 | $21,951,220 | 26 similar: 2–14 | No minimum reported similar: $5,000–$50,000 |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | Jun 28, 2013 | D | $22,754,148 | $22,754,148 | 63 | No minimum reported |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | May 2, 2013 | D | $1,800,000 | $1,800,000 | 8 | No minimum reported |
| EDGAR ↗ | FPSI, Inc. | Director | Jan 29, 2013 | D | $4,597,168 | $1,674,992 | 9 | No minimum reported |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | Dec 27, 2012 | D | $2,275,000 | $2,052,644 | 10 | No minimum reported |
| EDGAR ↗ | FlexEnergy, Inc. | Director | Nov 21, 2012 | D | Indefinite | $18,745,699 | 3 | $10,000 |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | May 7, 2012 | D | $5,000,000 | $5,000,000 | 6 | No minimum reported |
| EDGAR ↗ | FlexEnergy, Inc. | Director | Jan 5, 2012 | D | $10,000,000 | $5,000,000 | 1 | $10,000 |
| EDGAR ↗ | FlexEnergy, Inc. | Director | Dec 14, 2011 | D/A | $16,000,000 | $9,450,000 | 8 | $10,000 |
| EDGAR ↗ | VALERITAS INC | Director | Sep 20, 2011 | D | $150,606,043 | $75,165,098 | 22 | No minimum reported |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | May 20, 2011 | D | $8,000,000 | $8,000,000 | 7 | No minimum reported |
| EDGAR ↗ | FP Technology | Director | Jul 28, 2010 | D | $6,468,750 | $825,000 | 5 | No minimum reported |
| EDGAR ↗ | VERTOS MEDICAL INC | Director | Oct 27, 2009 | D | $15,487,856 | $15,487,856 | 28 | No minimum reported |
Every row is a Form D or D/A on which the issuer listed this name as a related person. Related-person names are matched on first + last name and the address state on the filing; records that share a name but could not be tied together by a second identifier are listed separately below.
"Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years (7 industry/exemption sets on this page); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.
Separate person records under the same name, not combined with this page. Each line says whether it is listed on an issuer this record is also listed on (a second identifier); where it is not, it could be the same person or a different one.
People and management entities the issuers listed as related persons on the same Form D filings as John Ryan. Source: the EDGAR rows in the table above. Showing the 40 with the most shared filings.
None found in sources searched.
Sources searched: SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 · Last checked Oct 23, 2026, 8:41 PM ET.
Export this report as PDF (members · included free during the launch period)
No corrections have been requested for this page.
Free. Logged with status: received → under review → fixed / confirmed with source.
If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.
Members get an email when John Ryan appears on a new Form D, or when a court case or SEC action is matched to them. See plans →